These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1594809)

  • 21. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exact group-sequential designs for clinical trials with randomized play-the-winner allocation.
    Stallard N; Rosenberger WF
    Stat Med; 2002 Feb; 21(4):467-80. PubMed ID: 11836730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early stopping rules--clinical perspectives and ethical considerations.
    Baum M; Houghton J; Abrams K
    Stat Med; 1994 Jul 15-30; 13(13-14):1459-69; discussion 1471-2. PubMed ID: 7973225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of clinical trials with early stopping: an investigation of potential bias.
    Schou IM; Marschner IC
    Stat Med; 2013 Dec; 32(28):4859-74. PubMed ID: 23824994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Designs for efficient clinical trials.
    Simon R
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stopping rules, interim analyses and data monitoring committees.
    Ashby D; Machin D
    Br J Cancer; 1993 Dec; 68(6):1047-50. PubMed ID: 8260354
    [No Abstract]   [Full Text] [Related]  

  • 27. Data monitoring committees, interim analysis and early termination in paediatric trials.
    Fernandes RM; van der Lee JH; Offringa M
    Acta Paediatr; 2011 Oct; 100(10):1386-92. PubMed ID: 21434998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Issues in designing sequential stopping rules for monitoring side effects in clinical trials.
    Goldman AI
    Control Clin Trials; 1987 Dec; 8(4):327-37. PubMed ID: 3327653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Bayesian with group sequential methods for monitoring clinical trials.
    Freedman LS; Spiegelhalter DJ
    Control Clin Trials; 1989 Dec; 10(4):357-67. PubMed ID: 2691203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized phase II trials with a prospective control.
    Jung SH
    Stat Med; 2008 Feb; 27(4):568-83. PubMed ID: 17573688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Bayesian Stopping Rule for Sequential Monitoring of Serious Adverse Events.
    Kashiwabara K; Matsuyama Y; Ohashi Y
    Ther Innov Regul Sci; 2014 Jul; 48(4):444-452. PubMed ID: 30235573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential stopping rules in clinical trials.
    McPherson K
    Stat Med; 1990 Jun; 9(6):595-600. PubMed ID: 2218163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bayesian randomized clinical trials: From fixed to adaptive design.
    Yin G; Lam CK; Shi H
    Contemp Clin Trials; 2017 Aug; 59():77-86. PubMed ID: 28455232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A curve-free Bayesian decision-theoretic design for two-agent Phase I trials.
    Lee BL; Fan SK; Lu Y
    J Biopharm Stat; 2017; 27(1):34-43. PubMed ID: 26882373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Planned versus attained design in phase II clinical trials.
    Green SJ; Dahlberg S
    Stat Med; 1992 May; 11(7):853-62. PubMed ID: 1604065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of a new multinomial phase II stopping rule using response and early progression.
    Dent S; Zee B; Dancey J; Hanauske A; Wanders J; Eisenhauer E
    J Clin Oncol; 2001 Feb; 19(3):785-91. PubMed ID: 11157032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Size of cancer clinical trials and stopping rules.
    Pocock SJ
    Br J Cancer; 1978 Dec; 38(6):757-66. PubMed ID: 369589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of phase II clinical trials in cancer using decision theory.
    Sylvester RJ; Staquet MJ
    Cancer Treat Rep; 1980; 64(2-3):519-24. PubMed ID: 7407793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential clinical trials in cancer research.
    George SL
    Cancer Treat Rep; 1980; 64(2-3):393-7. PubMed ID: 7407775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stopping guidelines for clinical trials with multiple treatments.
    Hughes MD
    Stat Med; 1993 May; 12(10):901-15. PubMed ID: 8337547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.